|
Market Closed -
Nasdaq
16:00:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 7.050 USD | -2.76% |
|
+3.68% | -71.80% |
| 10-15 | Olema Pharmaceuticals, Inc. Announces Board and Committee Changes | CI |
| 09-15 | Olema Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 01:50 PM |
| Market Cap | 617M 550M 509M 461M 868M 58.21B 878M 6.1B 2.39B 30.6B 2.31B 2.27B 97.5B | P/E 2026 * |
-2.91x | P/E 2027 * | -2.65x |
|---|---|---|---|---|---|
| Enterprise Value | 487M 434M 402M 364M 685M 45.96B 693M 4.82B 1.89B 24.16B 1.83B 1.79B 76.97B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 83.6x |
| Free-Float |
98.24% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OLMA | Delayed | |
CBOE
| OLMA | Real-time |
Last Transcript: Olema Pharmaceuticals, Inc.
| 1 day | -2.76% | ||
| 1 week | +3.68% | ||
| Current month | -18.40% | ||
| 1 month | -26.79% | ||
| 3 months | -39.17% | ||
| 6 months | -57.61% | ||
| Current year | -71.80% |
| 1 week | 6.48 |  | 7.61 |
| 1 month | 6.48 | | 9.64 |
| Current year | 6.48 | | 29.5 |
| 1 year | 6.48 | | 36.26 |
| 3 years | 2.86 | | 36.26 |
| 5 years | 2 | | 36.26 |
| 10 years | 2 | | 60.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean Bohen
CEO | Chief Executive Officer | 59 | 2020-08-31 |
Jason O’Byrne
DFI | Director of Finance/CFO | 57 | 2026-08-10 |
| Chief Tech/Sci/R&D Officer | - | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andy Rappaport
BRD | Director/Board Member | 68 | 2012-12-31 |
Graham Walmsley
BRD | Director/Board Member | 39 | 2020-02-29 |
Cynthia Butitta
BRD | Director/Board Member | 71 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Free | Chief Financial Officer | 650,000 | 0.7429% | ||
| 7/24/26 | Sell | Founder | -12,500 | 0.0143% | ||
| 6/18/26 | Free | Director | 29,500 | 0.0338% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.76% | +3.68% | -14.86% | -33.43% | 634M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.34B | |
| +0.82% | +5.41% | +8.05% | +73.53% | 54.82B | |
| -0.22% | +6.53% | +11.68% | +87.32% | 52.92B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 44.09B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.72B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 42.13B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 33.96B | |
| -6.32% | -5.14% | +28.81% | -0.02% | 26.17B | |
| +0.69% | +5.60% | +36.60% | +26.94% | 23.37B | |
| Average | -0.55% | +4.63% | +44.29% | +106.64% | 38.81B | |
| Weighted average by Cap. | -0.04% | +4.54% | +49.95% | +127.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.34M 5.65M 5.23M 4.73M 8.92M 598M 9.03M 62.73M 24.61M 315M 23.79M 23.29M 1B |
| Net income | -246M -219M -203M -184M -346M -23.21B -350M -2.43B -955M -12.2B -923M -904M -38.88B | -294M -262M -242M -219M -413M -27.71B -418M -2.9B -1.14B -14.56B -1.1B -1.08B -46.41B |
| Net Debt | -130M -116M -107M -96.96M -183M -12.25B -185M -1.28B -504M -6.44B -487M -477M -20.53B | -86.61M -77.18M -71.46M -64.67M -122M -8.17B -123M -857M -336M -4.3B -325M -318M -13.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | US$7.050 | -2.76% | 1,236,202 |
| 26-10-20 | US$7.250 | +1.97% | 1,871,547 |
| 26-10-19 | US$7.110 | +8.05% | 1,272,638 |
| 26-10-16 | US$6.580 | -4.22% | 1,081,294 |
| 26-10-15 | US$6.870 | +1.03% | 1,088,440 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OLMA Stock
Select your edition
All financial news and data tailored to specific country editions
